Overview

Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether Etodalac, Etoricoxib and Dexamethasone are effective for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Etoricoxib
Criteria
Inclusion Criteria:

- Patients who are refered for third molar extraction to our center

- Must be able to swallow tablets

Exclusion Criteria:

- Diabetes mellitus

- Thyroid diseases

- Cardiovascular diseases

- renal diseases

- hepatic diseases

- respiratory system diseases

- adrenal diseases

- Allergy to Etodalac, Etoricoxib or Dexamethasone

- Gastric ulcers

- psychiatric diseases

- Pregnant or breast feeding womans